| Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products S Pashikanti, DR de Alba, GA Boissonneault, D Cervantes-Laurean Free Radical Biology and Medicine 48 (5), 656-663, 2010 | 192 | 2010 |
| ezCADD: A rapid 2D/3D visualization-enabled web modeling environment for democratizing computer-aided drug design A Tao, Y Huang, Y Shinohara, ML Caylor, S Pashikanti, D Xu Journal of Chemical Information and Modeling 59 (1), 18-24, 2018 | 73 | 2018 |
| Ionic liquids for the removal of sulfur and nitrogen compounds in fuels: a review NE Paucar, P Kiggins, B Blad, K De Jesus, F Afrin, S Pashikanti, ... Environmental Chemistry Letters 19, 1205-1228, 2021 | 70 | 2021 |
| Cu-catalyzed borylative and silylative transformations of allenes: use of β-functionalized allyl copper intermediates in organic synthesis T Fujihara, Y Tsuji Synthesis 50 (09), 1737-1749, 2018 | 57 | 2018 |
| Biotransformation of citrus waste-I: production of biofuel and valuable compounds by fermentation N Mahato, K Sharma, M Sinha, A Dhyani, B Pathak, H Jang, S Park, ... Processes 9 (2), 220, 2021 | 53 | 2021 |
| Extraction, Isolation and Characterization of Bioactive Compounds from Artemisia and Their Biological Significance: A Review R Anibogwu, KD Jesus, S Pradhan, S Pashikanti, S Mateen, K Sharma Molecules 26 (22), 6995, 2021 | 48 | 2021 |
| Ex vivo detection of histone H1 modified with advanced glycation end products S Pashikanti, GA Boissonneault, D Cervantes-Laurean Free Radical Biology and Medicine 50 (10), 1410-1416, 2011 | 37 | 2011 |
| Extraction of lanthanides and actinides present in spent nuclear fuel and in electronic waste K De Jesus, R Rodriguez, DL Baek, RV Fox, S Pashikanti, K Sharma Journal of Molecular Liquids 336, 116006, 2021 | 34 | 2021 |
| Regio-and Stereoselective Copper (II)-Catalyzed Hydrosilylation of Activated Allenes in Water: Access to Vinylsilanes S Pashikanti, JA Calderone, MK Nguyen, CD Sibley, WL Santos Organic letters 18 (10), 2443-2446, 2016 | 34 | 2016 |
| Regioselective Diboron-Mediated Semireduction of Terminal Allenes AM Gates, WL Santos Synthesis 51 (24), 4619-4624, 2019 | 9 | 2019 |
| Total Synthesis and Structure–Activity Relationship Studies of the Cytotoxic Anhydrophytosphingosine Jaspine B (Pachastrissamine) S Pashikanti, R Ukani, SA David, A Datta Synthesis 49 (09), 2088-2100, 2017 | 9 | 2017 |
| Activity of the enantiomers of erythro‐3‐hydroxyaspartate at glutamate transporters and NMDA receptors AC Foster, YX Li, S Runyan, T Dinh, S Venadas, J Chen, S Pashikanti, ... Journal of Neurochemistry 136 (4), 692-697, 2016 | 9 | 2016 |
| Enantioselective Stereodivergent Synthesis of Jaspine B and 4-epi-Jaspine B from Axially Chiral Allenols H Alnazer, T Castellan, Y Salma, Y Génisson, S Ballereau Synlett 30 (02), 185-188, 2019 | 7 | 2019 |
| Rutin metabolites as powerful inhibitors of advanced glycation end products DC Laurean, S Pashikanti The FASEB Journal 22, 614.12-614.12, 2008 | 3 | 2008 |
| Natural products and small molecules targeting cellular ceramide metabolism to enhance apoptosis in cancer cells F Afrin, S Mateen, J Oman, JCK Lai, JJ Barrott, S Pashikanti Cancers 15 (18), 4645, 2023 | 2 | 2023 |
| Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues S Pashikanti, DJ Foster, Y Kharel, AM Brown, DR Bevan, KR Lynch, ... ACS bio & med Chem Au 2 (5), 469-489, 2022 | 2 | 2022 |
| Quantifying Fluorescently Labeled Ceramide Levels in Human Sarcoma Cell Lines in Response to a Sphingomyelin Synthase Inhibitor S Pashikanti, F Afrin, TC Meldrum, JL Stegelmeier, A Pavek, YA Habashi, ... Methods and Protocols 2 (3), 76, 2019 | 2 | 2019 |
| Metabolomics of Allium K Sharma, S Almulla, N Mahato, S Pradhan, S Mateen, S Pashikanti Edible Alliums: Botany, Production and Uses, 270-283, 2022 | 1 | 2022 |
| Formulation, Characterization, and In Vitro/In Vivo Efficacy Studies of a Novel Liposomal Drug Delivery System of Amphiphilic Jaspine B for Treatment of Synovial Sarcoma S Khajeh Pour, S Mateen, S Pashikanti, JJ Barrott, A Aghazadeh-Habashi Marine Drugs 20 (8), 509, 2022 | 1 | 2022 |
| Rutin derivatives as potent AGE inhibitors and its relevance in diabetes complications DC Laurean, S Pashikanti The FASEB Journal 21 (5), A633-A633, 2007 | 1 | 2007 |
